Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 31,188 followers.

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis: Objective The progress of neoadjuvant therapy for resectable locally advanced esophageal cancer… #oncology https://t.co/rmfT

06 Sep 2022

Reply Repost Favourite

RT @FrontOncology: New research: Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal…

05 Sep 2022

Reply Repost Favourite

New research: Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis: Objective The progress of neoadjuvant therapy for resectable locally advanced esophageal cancer… https://t.co

05 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.